LENZ Therapeutics, Inc.
LENZAs of the close on Sep 25, 2026
Price
$3.92
Market cap
$123M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$4.13
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How LENZ Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Optiver Holding B.V. | 2026-03-31 | 142 | $1.3K | SEC filing |
| Rinkey Investments | 2026-03-31 | 15,186 | $139K | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 95,235 | $870K | SEC filing |
| Allworth Financial LP | 2026-03-31 | 256 | $2.34K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 183,756 | $1.68M | SEC filing |
| BFSG, LLC | 2026-03-31 | 635 | $5.81K | SEC filing |
| Trexquant Investment LP | 2026-03-31 | 214,408 | $1.96M | SEC filing |
| Invesco Ltd. | 2026-03-31 | 14,927 | $137K | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 21,894 | $204K | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 1,075 | $9.84K | SEC filing |
| Connor, Clark & Lunn Investment Management Ltd. | 2026-03-31 | 37,314 | $341K | SEC filing |
| Parkside Financial Bank & Trust | 2026-03-31 | 55 | $504 | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 500,997 | $4.58M | SEC filing |
| Janney Montgomery Scott LLC | 2026-03-31 | 10,814 | Not shown | SEC filing |
| Schonfeld Strategic Advisors LLC | 2026-03-31 | 39,285 | $359K | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 16,220 | $148K | SEC filing |
| CWM, LLC | 2026-03-31 | 12,240 | $112K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 9,787 | $89.6K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 337 | $3.15K | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 149,544 | $1.37M | SEC filing |
- Each value is checked against LENZ Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at LENZ Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among LENZ Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-08-15 · Versant Venture Capital VI, L.P.: Larger than 32 of the 35 other insider sales of Common Stock on file. SEC filing
- 2025-07-10 · Versant Venture Capital VI, L.P.: Larger than 33 of the 35 other insider sales of Common Stock on file. SEC filing
- 2025-06-27 · Versant Venture Capital VI, L.P.: Larger than 34 of the 35 other insider sales of Common Stock on file. SEC filing
- 2025-06-10 · Versant Venture Capital VI, L.P.: Larger than all 35 other insider sales of Common Stock on file. SEC filing
- 2024-03-21 · RA Capital Healthcare Fund LP: Larger than all 28 other insider purchases of Common Stock on file. SEC filing
- 2022-04-12 · AKKARAJU SRINIVAS: Larger than 26 of the 28 other insider purchases of Common Stock on file. SEC filing
- 2021-06-29 · AKKARAJU SRINIVAS: Larger than 27 of the 28 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2026-03-27–2026-03-27: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2025-11-07–2025-11-07: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2024-05-13–2024-05-14: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-04-11–2022-04-12: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2021-06-29–2021-06-29: 5 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-27 | Chevallard Daniel R. · Chief Financial Officer | Common Stock | P — Open market or private purchase | +7,500 | 8.57 | SEC filing |
| 2026-03-27 | George Jeffrey P. · Director | Common Stock | P — Open market or private purchase | +5,592 | 8.92 | SEC filing |
| 2026-03-27 | Schimmelpennink Evert B. · President, CEO and Secretary | Common Stock | P — Open market or private purchase | +28,089 | 8.95 | SEC filing |
| 2025-11-17 | Olsson Shawn · Chief Commercial Officer | Common Stock | S — Open market or private sale | −4,212 | 25.74 | SEC filing |
| 2025-11-17 | Olsson Shawn · Chief Commercial Officer | Common Stock | S — Open market or private sale | −5,788 | 26.37 | SEC filing |
| 2025-11-07 | MCCOLLUM JAMES W · Director | Common Stock | P — Open market or private purchase | +10,500 | 22.79 | SEC filing |
| 2025-11-07 | Chevallard Daniel R. · Chief Financial Officer | Common Stock | P — Open market or private purchase | +2,178 | 22.76 | SEC filing |
| 2025-11-07 | Chevallard Daniel R. · Chief Financial Officer | Common Stock | P — Open market or private purchase | +20 | 22.71 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-15 | MCCOLLUM JAMES W · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-06-15 | RA Capital Healthcare Fund LP · Director, 10% owner | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-06-15 | Guerard Frederic · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-06-15 | Scheiner Zachary · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-06-15 | George Jeffrey P. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-06-15 | Thunen Shelley B · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-06-15 | Drapkin Kimberlee C · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +22,100 | SEC filing |
| 2026-01-02 | Odrich Marc · Chief Medical Officer | Restricted Stock Unit | A — Grant, award, or other acquisition | +14,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-03-21 | Versant Venture Capital VI, L.P. · 10% owner | Common Stock | J — Other acquisition or disposition | +598,203 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.